PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 16, 2006 Subscribe to this News Feed    
 

The combination of Permatec in Switzerland and Medi-Ject in the US has resulted in Antares Pharma, a company which aims to become a leader in drug-delivery systems

Research and Markets has announced the addition of Espicoms Business Intelligences Antares Pharma Drug-Delivery Company Intelligence Report to their offering.

Dublin (PRWEB) February 16, 2006 -- Research and Markets (http://www.researchandmarkets.com/reports/c32939) has announced the addition of Espicoms Business Intelligences Antares Pharma Drug-Delivery Company Intelligence Report to their offering.

Industry and commercial interest in drug delivery has been building steadily. The benefits to patients can be seen in improved compliance and medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes and bring new therapies to the market that would, previously, have been impossible. These detailed company reports bring into focus the companies which driving growth and innovation in drug delivery. Over 140 leading players are examined with details for Company Overview, Key Personnel, Key Milestones, Products/Technologies, Research Strategy, Agreements, Financial Data and Associated Companies (if any) provided for each.

Contents Include:

1. Key Personnel
2. Company Overview
3. Key Milestones
4. Products/Technologies
5. Research Activities
6. Agreements
7. Key Financial Data
8. Competition


The combination of Permatec in Switzerland and Medi-Ject in the US has resulted in Antares Pharma, a company which aims to become a leader in drug-delivery systems though the combined technologies of needlefree, mini-needle and transdermal gel.

Antares has an established, marketed product line of injector systems and transdermal technologies. In addition, the company has the opportunity to blend its injection and gel technologies to create new drug-delivery solutions, promising a broad array of future product opportunities. Antares plans to continue to research and develop new delivery technologies or acquire new technologies to sustain its competitive position.

For more information visit http://www.researchandmarkets.com/reports/c32939

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Laura Wood
RESEARCH AND MARKETS
353 1 4151254
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.